title: Clinical pharmacology of carvedilol in normal volunteers.
abstract: The mechanism of the vasodilatory action of carvedilol (BM 14190), a new antihypertensive agent, was investigated in normal volunteers. Intra-arterial blood pressure and ECG were monitored continuously. Carvedilol (1 mg/min for 15 minutes) produced a rapid reduction in blood pressure and a transient increase in heart rate. At the end of infusion, systolic and diastolic blood pressure were reduced by 23% (-32.3 mm Hg) and 18% (-13.6 mm Hg), respectively, whereas heart rate was not different from baseline. At the doses used, the hypotensive effect of carvedilol was greater than that of labetalol (36 and 72 mg in 15 minutes). Carvedilol and labetalol antagonized isoproterenol-induced hypotension and tachycardia, at serum levels greater than or equal to 8 and 20 mg/ml, respectively. Both drugs antagonized phenylephrine pressor effects. A similar degree of inhibition (25% of control) of pressor effects was observed for carvedilol and labetalol when their respective serum concentrations were 23 ng/ml and 80 ng/ml. Neither carvedilol nor labetalol had any effect on AII pressor responses. Carvedilol serum levels as high as 150 ng/ml failed to inhibit AII-induced pressor responses. Our results suggest that at the doses used in this study, carvedilol has both alpha 1-and nonselective beta-receptor blocking properties. Moreover, carvedilol is approximately three to five times more potent than labetalol in blocking alpha 1-and beta-receptors and in reducing blood pressure.
mesh_terms: D000328:Adult; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D001794:Blood Pressure / Q000187:drug effects; D002227:Carbazoles / Q000378:metabolism / Q000494:pharmacology*; D000077261:Carvedilol; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D007700:Kinetics; D007741:Labetalol / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D010656:Phenylephrine / Q000037:antagonists & inhibitors; D011412:Propanolamines; D011897:Random Allocation; D011941:Receptors, Adrenergic / Q000187:drug effects
chemical_list: D002227:Carbazoles; D011412:Propanolamines; D011941:Receptors, Adrenergic; D000077261:Carvedilol; D000804:Angiotensin II; D010656:Phenylephrine; D007545:Isoproterenol; D007741:Labetalol